Skip to main content
. 2021 Jul 7;16(7):e0252924. doi: 10.1371/journal.pone.0252924

Fig 4.

Fig 4

A) Dotplots show the substance classes of designated drugs in GBM, B) Pie chart shows the mode of action of designated immunotherapies/ cellular therapies for glioblastomas.